|
|
Volumn 10, Issue 3, 2001, Pages 257-263
|
|
An intervention trial to inhibit the progression of precancerous gastric lesions: Compliance, serum micronutrients and S-allyl cysteine levels, and toxicity
a
c
WESTAT
(United States)
|
|
Author keywords
Compliance; Intervention Trial; Precancerous Gastric lesions; Toxicity
|
|
Indexed keywords
ALPHA TOCOPHEROL;
ASCORBIC ACID;
GARLIC OIL;
PLACEBO;
S ALLYLCYSTEINE;
TRACE ELEMENT;
ADULT;
AGED;
ARTICLE;
BLOOD LEVEL;
CHINA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIET SUPPLEMENTATION;
HUMAN;
LONG TERM CARE;
NORMAL HUMAN;
PATIENT COMPLIANCE;
PRECANCER;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
STOMACH CANCER;
TREATMENT OUTCOME;
TUMOR GROWTH;
ADULT;
AGED;
AMOXICILLIN;
ANTIOXIDANTS;
ASCORBIC ACID;
BETA CAROTENE;
CHINA;
DOUBLE-BLIND METHOD;
DRUG THERAPY, COMBINATION;
FEMALE;
GARLIC;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HUMANS;
MALE;
MIDDLE AGED;
OMEPRAZOLE;
PATIENT COMPLIANCE;
PENICILLINS;
PHYTOTHERAPY;
PLANTS, MEDICINAL;
PRECANCEROUS CONDITIONS;
PREVALENCE;
SELENIUM;
STOMACH NEOPLASMS;
TREATMENT OUTCOME;
VITAMIN E;
|
|
EID: 0034988736
PISSN: 09598278
EISSN: None
Source Type: Journal
DOI: 10.1097/00008469-200106000-00009 Document Type: Article |
|
Times cited : (55)
|
|
References (16)
|
